Saskia D van Asten

5PUBLICATIONS
25CO-AUTHORS
Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 22, 2026
DuoBody®-FAPαxDR4 is a novel DR4 agonist that induces potent antitumor activity through FAPα-dependent, DR4-transactivation-mediated apoptosis.

|Oct 21, 2021
Bayesian log-normal deconvolution for enhanced in silico microdissection of bulk gene expression data.

Bárbara Andrade Barbosa, Saskia D van Asten, Ji Won Oh

|Jul 03, 2021
Soluble FAS Ligand Enhances Suboptimal CD40L/IL-21-Mediated Human Memory B Cell Differentiation into Antibody-Secreting Cells.

Saskia D van Asten, Peter-Paul Unger, Casper Marsman

|Feb 04, 2021
T cells expanded from renal cell carcinoma display tumor-specific CD137 expression but lack significant IFN-γ, TNF-α or IL-2 production.

Saskia D van Asten, Rosa de Groot, Marleen M van Loenen

|Jun 15, 2018
Secretome Screening Reveals Fibroblast Growth Factors as Novel Inhibitors of Viral Replication.

Saskia D van Asten, Matthijs Raaben, Benjamin Nota

Pageof 1

Frequent Collaborators

2 joint publications

Robbert M Spaapen

1 joint publications

Rosa de Groot

1 joint publications

Monika C Wolkers

1 joint publications

Casper Marsman